Choroidal neovascular membrane in Best juvenile dystrophy treated with intravitreal bevacizumab.
Corina
C
Taban
A
A
Merticariu
Livia
L
Melcioiu
Anca
A
Oprescu
R
R
Ionescu
A
A
Iacob
M
M
Pienaru
Daniela
D
Desliu
F
F
Balta
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab; D002648:Child; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000235:genetics; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections / Q000379:methods; D008297:Male; D009035:Mothers; D010375:Pedigree; D016896:Treatment Outcome; D014792:Visual Acuity; D057826:Vitelliform Macular Dystrophy / Q000150:complications*
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab